Trump Administration Plans Broader Testosterone Access as US Prescriptions Near 12 Million
Updated
Updated · The New York Times · May 12
Trump Administration Plans Broader Testosterone Access as US Prescriptions Near 12 Million
1 articles · Updated · The New York Times · May 12
April plans from the Trump administration’s health department would widen men’s access to testosterone replacement therapy, a treatment doctors say could help more patients with clinically low hormone levels.
Nearly 12 million testosterone prescriptions were filled in 2025, up from fewer than 1 million in 2000, with additional demand increasingly flowing through telehealth platforms marketing T.R.T. as a lifestyle product.
Doctors interviewed by the Times backed broader access for untreated men but warned online hypermasculine culture is pushing younger men toward unrealistic expectations about a therapy that carries real risks.
Men are typically diagnosed only when symptoms such as fatigue, muscle loss, sexual dysfunction or depression coincide with blood testosterone below 300 nanograms per deciliter.
Is the testosterone boom a cure for a men's health crisis or a risky, profitable new cultural trend?
With online T.R.T. ads targeting young men, what are the unspoken risks to their future fertility?
Beyond therapy, could invisible microplastics be the real culprit behind declining male hormones and fertility?